Cargando…

Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?

INTRODUCTION: COVID-19 has caused approximately one million deaths worldwide as of November 24, 2020. Markers of disease activity like ferritin, C-reactive protein (CRP), and D-dimers are frequently monitored to detect the best opportunity for intensive treatment. METHODS: All patients of >18 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadeem, Rashid, Elhoufi, Ashraf Mahmoud, Iqbal, Naheed Elahi, Obaida, Zainab Abdulameer, Elgohary, Doaa Mohamed, Singh, Mukesh Kumar, Zoraey, Shymaa Farouk, Abdalla, Rami M., Eltayeb, Sara Yousif, Danthi, Crystal Sharon, Azaza, Nouha, Ahmed, Waleed Mohamed, Hafeez, Muzammil, AlSada, Maryam, Mir, Fatima Farid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089454/
http://dx.doi.org/10.1159/000514406
_version_ 1783687043436511232
author Nadeem, Rashid
Elhoufi, Ashraf Mahmoud
Iqbal, Naheed Elahi
Obaida, Zainab Abdulameer
Elgohary, Doaa Mohamed
Singh, Mukesh Kumar
Zoraey, Shymaa Farouk
Abdalla, Rami M.
Eltayeb, Sara Yousif
Danthi, Crystal Sharon
Azaza, Nouha
Ahmed, Waleed Mohamed
Hafeez, Muzammil
AlSada, Maryam
Mir, Fatima Farid
author_facet Nadeem, Rashid
Elhoufi, Ashraf Mahmoud
Iqbal, Naheed Elahi
Obaida, Zainab Abdulameer
Elgohary, Doaa Mohamed
Singh, Mukesh Kumar
Zoraey, Shymaa Farouk
Abdalla, Rami M.
Eltayeb, Sara Yousif
Danthi, Crystal Sharon
Azaza, Nouha
Ahmed, Waleed Mohamed
Hafeez, Muzammil
AlSada, Maryam
Mir, Fatima Farid
author_sort Nadeem, Rashid
collection PubMed
description INTRODUCTION: COVID-19 has caused approximately one million deaths worldwide as of November 24, 2020. Markers of disease activity like ferritin, C-reactive protein (CRP), and D-dimers are frequently monitored to detect the best opportunity for intensive treatment. METHODS: All patients of >18 years of age were included. The primary variables of interest, ferritin, CRP, and D-dimers, for each patient throughout hospitalization were recorded. Primary clinical outcomes of length of stay in ICU and survival were recorded. DEMOGRAPHICS: age, gender, BMI, and nationality. Ferritin, CRP, and D-dimers were recorded daily if available for the whole ICU stay, and all other variables were recorded on admission day to ICU. RESULTS: The sample includes 235 records. More than 95% of patients have all markers on the day of admission to ICU were ferritin (median 1,278; IQR 1,424), D-dimer 1.21 (3.4), and CRP 129.5 (121). Daily average levels of markers were different from their admission day level: ferritin 1,395 (1,331), D-dimer 3.11 (5.52), and CRP 107 (75.8). Multiple logistic regression analysis determined that average CRP during the stay was the only predictor of survival. DISCUSSION: Data on markers utilization to detect the acute phase of inflammation help clinicians focus on the opportunity window for intensive treatment. CONCLUSION: Average CRP during the stay in ICU is higher than CRP on admission. Average CRP is the only factor that predicts survival.
format Online
Article
Text
id pubmed-8089454
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-80894542021-05-03 Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? Nadeem, Rashid Elhoufi, Ashraf Mahmoud Iqbal, Naheed Elahi Obaida, Zainab Abdulameer Elgohary, Doaa Mohamed Singh, Mukesh Kumar Zoraey, Shymaa Farouk Abdalla, Rami M. Eltayeb, Sara Yousif Danthi, Crystal Sharon Azaza, Nouha Ahmed, Waleed Mohamed Hafeez, Muzammil AlSada, Maryam Mir, Fatima Farid Dubai Medical Journal Educational Corner − Research Article INTRODUCTION: COVID-19 has caused approximately one million deaths worldwide as of November 24, 2020. Markers of disease activity like ferritin, C-reactive protein (CRP), and D-dimers are frequently monitored to detect the best opportunity for intensive treatment. METHODS: All patients of >18 years of age were included. The primary variables of interest, ferritin, CRP, and D-dimers, for each patient throughout hospitalization were recorded. Primary clinical outcomes of length of stay in ICU and survival were recorded. DEMOGRAPHICS: age, gender, BMI, and nationality. Ferritin, CRP, and D-dimers were recorded daily if available for the whole ICU stay, and all other variables were recorded on admission day to ICU. RESULTS: The sample includes 235 records. More than 95% of patients have all markers on the day of admission to ICU were ferritin (median 1,278; IQR 1,424), D-dimer 1.21 (3.4), and CRP 129.5 (121). Daily average levels of markers were different from their admission day level: ferritin 1,395 (1,331), D-dimer 3.11 (5.52), and CRP 107 (75.8). Multiple logistic regression analysis determined that average CRP during the stay was the only predictor of survival. DISCUSSION: Data on markers utilization to detect the acute phase of inflammation help clinicians focus on the opportunity window for intensive treatment. CONCLUSION: Average CRP during the stay in ICU is higher than CRP on admission. Average CRP is the only factor that predicts survival. S. Karger AG 2021-04-14 /pmc/articles/PMC8089454/ http://dx.doi.org/10.1159/000514406 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Educational Corner − Research Article
Nadeem, Rashid
Elhoufi, Ashraf Mahmoud
Iqbal, Naheed Elahi
Obaida, Zainab Abdulameer
Elgohary, Doaa Mohamed
Singh, Mukesh Kumar
Zoraey, Shymaa Farouk
Abdalla, Rami M.
Eltayeb, Sara Yousif
Danthi, Crystal Sharon
Azaza, Nouha
Ahmed, Waleed Mohamed
Hafeez, Muzammil
AlSada, Maryam
Mir, Fatima Farid
Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
title Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
title_full Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
title_fullStr Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
title_full_unstemmed Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
title_short Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
title_sort prediction of cytokine storm and mortality in patients with covid-19 admitted to icu: do markers tell the story?
topic Educational Corner − Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089454/
http://dx.doi.org/10.1159/000514406
work_keys_str_mv AT nadeemrashid predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT elhoufiashrafmahmoud predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT iqbalnaheedelahi predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT obaidazainababdulameer predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT elgoharydoaamohamed predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT singhmukeshkumar predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT zoraeyshymaafarouk predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT abdallaramim predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT eltayebsarayousif predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT danthicrystalsharon predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT azazanouha predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT ahmedwaleedmohamed predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT hafeezmuzammil predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT alsadamaryam predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory
AT mirfatimafarid predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory